BASF plans to invest EUR 200 million ($227.6 million) to expand its manufacturing capacity for ibuprofen by building a new plant to in Ludwigshafen, Germany and by increasing capacity at its production site in Bishop, Texas.

The expansion at Bishop, Texas will come onstream in early 2018 while the new plant is scheduled to come onstream in 2021. BASF has been manufacturing ibuprofen at its production site in Bishop for more than 20 years.

Source: BASF